| Members |
targetComponentId |
| Iridectomy with corneoscleral section, peripheral, for glaucoma |
Iridectomy |
| Iridotomy NEC |
Iridotomy (procedure) |
| Irinotecan hydrochloride 20mg/mL injection |
Product containing precisely irinotecan hydrochloride trihydrate 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Irinotecan hydrochloride 20mg/mL injection solution 2mL vial |
Product containing precisely irinotecan hydrochloride trihydrate 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Irinotecan hydrochloride 20mg/mL injection solution 5mL vial |
Product containing precisely irinotecan hydrochloride trihydrate 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| irinotecanhydrochloridtrihydrat 20 mg/ml koncentrat til infusionsvæske, hætteglas a 2 ml |
Product containing precisely irinotecan hydrochloride trihydrate 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| irinotecanhydrochloridtrihydrat 20 mg/ml koncentrat til infusionsvæske, hætteglas a 5 ml |
Product containing precisely irinotecan hydrochloride trihydrate 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Iris coloboma with ptosis, hypertelorism, and mental retardation |
Baraitser-Winter syndrome (BWS) is a malformation syndrome, characterized by facial dysmorphism (hypertelorism with ptosis, broad bulbous nose, ridged metopic suture, arched eyebrows, progressive coarsening of the face), ocular coloboma, pachygyria and/or band heterotopias with antero-posterior gradient, progressive joint stiffening, and intellectual deficit of variable severity, often with severe epilepsy. Pachygyria - epilepsy - intellectual disability - dysmorphism (Fryns-Aftimos syndrome) corresponds to the appearance of BWS in elderly patients. |
| Irit med inflammatorisk tarmsygdom |
Iritis co-occurrent with inflammatory bowel disease |
| Jernmiddel |
Iron compound |
| ferrit 23,4 mg (Fe) brev granulat til suspension |
Iron ferrite only product |
| Iron ferrite 23.4mg(Fe)/sachet granules for suspension |
Iron ferrite only product |
| Iron kinetics NOS |
Iron kinetics study |
| Iron kinetics NOS |
Iron kinetics study |
| Iron poisoning |
Poisoning by iron |
| Jernsalttatovering |
Iatrogenic tattoo |
| Irrigation of bronchus NEC |
Lavage of bronchus |
| Irrigation of bronchus NEC |
Lavage of bronchus |
| Irrigation of organ NOC |
Administration that washes with a stream of liquid |
| irritans |
Irritant (substance) |
| Ischaemic heart disease NOS |
Ischemic heart disease (disorder) |
| Iskæmisk hjertesygdom, ikke nærmere specificeret |
Ischemic heart disease (disorder) |
| Ischio-vertebral syndrome |
A rare primary bone dysplasia characterized by costovertebral ossification defects with small chest, abnormal vertebral segmentation, and posterior rib gaps containing incompletely differentiated mesenchymal tissue. Consistent dysmorphic craniofacial features include ocular hypertelorism, epicanthal folds, depressed nasal bridge with short nose, and low-set ears. The most common extraosseous manifestations are renal abnormalities such as multicystic kidneys. The disease is usually perinatally lethal due to respiratory insufficiency. |
| Ischium X-ray |
Plain X-ray of ischium |
| Røntgenundersøgelse af os ischii |
Plain X-ray of ischium |
| Ischium X-ray |
Plain X-ray of ischium |
| væskeformigt isofluran 99,9 % |
Product containing precisely isoflurane 999 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
| Isogeneic graft |
Syngraft |
| Isoleret dekstrokardi |
A rare, congenital, non-syndromic, developmental defect during embryogenesis characterized by positioning of the heart in the right hemithorax, with the base and apex of the heart pointing caudally and to the right, due to abnormalities of embryologic origin that are intrinsic to the heart itself. Situs inversus or situs solitus may be associated, with extracardiac visceral transposition anomalies usually present in the former case and additional cardiac defects (e.g. septal defects, transposition of the great arteries, double-outlet right ventricle, anomalous pulmonary venous return, tetralogy of Fallot) frequently observed in both cases. |
| Isolated environment |
Isolating environment |
| Isometheptene mucate+acetaminophen |
Product containing isometheptene and paracetamol (medicinal product) |
| isoniazid 50 mg/5 ml syrup til oral anvendelse |
Isoniazid 10 mg/mL oral solution |
| Isoproterenol hydrochloride 1:50,000mg injection |
Isoprenaline hydrochloride 200 microgram/mL solution for injection |
| isoproterenolhydrochlorid 1:50.000 mg (0,2 mg/ml) injektionsvæske, opløsning, hætteglas a 10 ml |
Product containing only isoprenaline in parenteral dose form (medicinal product form) |
| isoproterenolhydrochlorid 1:50.000 mg (0,2 mg/ml) injektionsvæske, opløsning, ampul a 1 ml |
Isoprenaline hydrochloride 200 microgram/mL solution for injection |
| isoproterenolhydrochlorid 1:50.000 mg (0,2 mg/ml) injektionsvæske, opløsning, ampul a 5 ml |
Isoprenaline hydrochloride 200 microgram/mL solution for injection |
| Isoproterenol hydrochloride 1:5000mg injection |
Isoprenaline hydrochloride 200 microgram/mL solution for injection |
| isoproterenolhydrochlorid 1:5000 mg injektionsvæske, opløsning, ampul a 10 ml |
Product containing only isoprenaline in parenteral dose form (medicinal product form) |
| isoproterenolhydrochlorid 1:5000 mg injektionsvæske, opløsning, flaske a 125 ml |
Product containing only isoprenaline in parenteral dose form (medicinal product form) |
| isoproterenolhydrochlorid 1:5000 mg injektionsvæske, opløsning, hætteglas a 1 ml |
Isoprenaline hydrochloride 200 microgram/mL solution for injection |
| isoproterenolhydrochlorid 1:5000 mg injektionsvæske, opløsning, hætteglas a 5 ml |
Isoprenaline hydrochloride 200 microgram/mL solution for injection |
| allergi over for isosorbiddinitrat |
Allergy to isosorbide (finding) |
| isosorbidmononitrat 120 mg tablet med modificeret udløsning |
Product containing only isosorbide in oral dose form (medicinal product form) |
| Isosorbide mononitrate 120mg prolonged-release oral tablet |
Product containing only isosorbide in oral dose form (medicinal product form) |
| Isosorbide mononitrate 120mg tablet |
Product containing only isosorbide in oral dose form (medicinal product form) |
| isosorbidmononitrat 300 mg tablet med modificeret udløsning |
Product containing only isosorbide in oral dose form (medicinal product form) |
| Isosorbide mononitrate 30mg prolonged-release oral tablet |
Product containing only isosorbide in oral dose form (medicinal product form) |
| allergi over for isosorbidmononitrat |
Allergy to isosorbide (finding) |
| Isotope dynamic scan NOS |
Isotope dynamic scanning |
| Isotope dynamic scan NOS |
Isotope dynamic scanning |
| Isotope haematology NOS |
Radioisotope study of hematopoietic system |
| Isotope hematology NOS |
Radioisotope study of hematopoietic system |
| Isotope static scan NOS |
Isotope distribution static scan |
| Isotope static scan NOS |
Isotope distribution static scan |
| Isotope uptake/excret NOS |
Isotope uptake/excretion studies |
| Isotope uptake/excret NOS |
Isotope uptake/excretion studies |
| Ispaghula husk 3.4g/sachet conventional release oral powder |
Product containing only ispaghula husk in oral dose form (medicinal product form) |
| loppefrøskaller 3,4 g/brev sukkerfrit pulver |
Product containing only ispaghula husk in oral dose form (medicinal product form) |
| Ispaghula husk 3.5g/sachet conventional release oral powder |
Product containing only ispaghula husk in oral dose form (medicinal product form) |
| Ispaghula husk 3.5g/sachet granules |
Product containing only ispaghula husk in oral dose form (medicinal product form) |
| loppefrøskaller 3,5 g/brev sukkerfrit pulver |
Product containing only ispaghula husk in oral dose form (medicinal product form) |
| Ispaghula husk 3.5g/sachet s/f powder |
Product containing only ispaghula husk in oral dose form (medicinal product form) |
| Ispaghula husk lemon/lime 3.4g/sachet s/f powder |
Product containing only ispaghula husk in oral dose form (medicinal product form) |
| Ispaghula husk orange 3.4g/sachet s/f powder |
Product containing only ispaghula husk in oral dose form (medicinal product form) |
| ispaghulaspecifikt ekstrakt |
Product containing psyllium (medicinal product) |
| isradipin 5 mg tablet |
Product containing only isradipine in oral dose form (medicinal product form) |
| Isradipine 5mg prolonged-release oral tablet |
Product containing only isradipine in oral dose form (medicinal product form) |
| itraconazol 10 mg/ml koncentrat til infusionsvæske, ampul a 25 ml |
Itraconazole 10 mg/mL solution for injection |
| Jacksons fokal eller motorisk epilepsi |
A type of focal epilepsy where all the seizures originate within the primary motor cortex area of the frontal lobe. |
| Janitor |
Building caretaker |
| Jaw-blinking |
Jaw-winking syndrome |
| Jejunal flap |
Flap (substance) |
| Jejunoscopy: [diagnostic NOS] or [NEC] |
Endoscopy of jejunum |
| Jewish nose |
Nose finding |
| Job details NOS |
Job details - finding |
| Joboplysninger, ikke nærmere specificeret |
Job details |
| Joint ankylosis of other specified site |
Ankylosis of joint |
| Ledankylose med anden specificeret lokalisation |
Ankylosis of joint |
| Joint contracture of other specified site |
Contracture of joint |
| kontraktur i led med anden specificeret lokalisation |
Contracture of joint |
| Joint derangement NOS |
A general term used to refer to any damage to or abnormality of the joint structure or surrounding soft tissue resulting in a limitation of joint movement. |
| derangement i led, ikke nærmere specificeret |
A general term used to refer to any damage to or abnormality of the joint structure or surrounding soft tissue resulting in a limitation of joint movement. |
| Joint disorders NOS |
Arthropathy (disorder) |
| Ledlidelser, ikke nærmere specificeret |
Arthropathy (disorder) |
| Joint effusion of other specified site |
Effusion of joint (disorder) |
| væskeansamling i led med anden specificeret lokalisation |
Effusion of joint (disorder) |
| Ledexcision, ikke nærmere specificeret |
Excision of joint |
| Joint excision NOS |
Excision of joint |
| Joint incision NOS |
Arthrotomy |
| Ledincision, ikke nærmere specificeret |
Arthrotomy |
| Joint reconstruction |
Reconstruction of joint |
| Joint stiffness (& [NOS]) |
Joint stiffness |
| Joint stiffness (& [NOS]) |
Joint stiffness |
| Ledstivhed ikke klassificeret andetsteds, ikke specificeret andetsteds |
Joint stiffness |
| Ledstivhed, ikke specificeret andetsteds |
Joint stiffness |
| Joint stiffness NOS |
Joint stiffness |
| regionær ledstruktur |
Joint structure |
| ledstruktur i skulderbæltet |
Joint structure of shoulder region |
| Judgement finding |
Judgement |
| Jumping Frenchmen of Maine disease |
Jumping disease |
| juvenil kronisk artrit |
Juvenile idiopathic arthritis (disorder) |
FHIR